Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating chronic colitis and ulcerative colitis, and preparation method

A technology for ulcerative colitis and chronic colitis, which can be used in drug combinations, pharmaceutical formulations, and medical preparations containing active ingredients, etc., can solve the problems of lack of therapeutic effect, difficulties, and insufficient research and publicity. achieve good curative effect

Active Publication Date: 2007-12-26
杨洪英
View PDF0 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Because the disease does not affect people's normal life and work in the early stage of the disease, and the research and publicity of the disease in the world is not in place, most patients lack sufficient understanding and attention to the pathogenesis and harmfulness of the disease. And some patients have a fluke mentality of "incurable self-healing" after the onset of the disease, which delays the best treatment period
Since the disease is not caused by pathogenic bacteria, most patients abuse antibiotics blindly for anti-inflammation and sterilization after seeking medical treatment, which not only fails to achieve therapeutic effect but also destroys the normal flora of the gastrointestinal tract, which brings inconvenience and inconvenience to future conventional treatment. difficulty! Due to the above reasons and some other improper treatment behaviors, colitis is stubborn and difficult to heal, which seriously threatens human health! Enteropathy is caused by the dysfunction of the patient's own digestive system and the relative disorder of the internal organs.
If monotherapy is used to treat intestinal lesions, it will only temporarily relieve the symptoms, but cannot be completely cured, and it is easy to relapse, which will bring great pain to the patient
[0004] At present, most ulcerative colitis UC and chronic enteritis use aminosalicylic acid and glucocorticoids to control inflammation as soon as possible and relieve symptoms during the active period, and use biological agents such as berberine and colonin probiotics in the remission period. The short-term use of similar drugs will recur for 3-5 years, and the long-term use will be life-long. And 5-ASA glucocorticoids have no maintenance effect and are dependent. If 5-ASA and immunosuppressants are ineffective, anti-tumor necrosis factor should be used. a(TNF-a) monoclonal antibody (infliximab) and colectomy, current treatment methods bring great pain and disadvantage to patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating chronic colitis and ulcerative colitis, and preparation method
  • Medicine for treating chronic colitis and ulcerative colitis, and preparation method
  • Medicine for treating chronic colitis and ulcerative colitis, and preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0184] Get the raw material medicine (weight unit kilogram): spider incense 15, kudzu root 15, chrysanthemum 15, honeysuckle 10, berberine 15, peony root 15, woody fragrance 15, notoginseng 8, Patrinia 8, astragalus 15, dried ginger 5 , licorice 6, jujube 5.

[0185] Prepare as follows:

[0186] 1) Soak Panax notoginseng in 75% ethanol for 24 hours, infiltrate and concentrate to form an extract for later use, decoct the dregs with water for 3 times, filter and concentrate to form an extract for later use;

[0187] 2) Decoct licorice, jujube, kudzu root, spider incense, Patrinia, Hangbai, honeysuckle, and astragalus with water for 3 times and concentrate to make an extract for later use;

[0188] 3) Coptis chinensis, Scutellaria baicalensis, and woody fine powder are sieved with 80 mesh and set aside;

[0189]4) Mix the extracts in steps 1), 2) and the fine powder in step 3) and dry them below 80°C to obtain a mixed powder;

[0190] 5) Put the mixed powder into capsules (0.3...

Embodiment 2

[0192] Get the raw material medicine (weight unit kilogram): spider incense 10, kudzu root 10, Scutellaria baicalensis 10, honeysuckle 5, coptis 10, peony root 10, woody fragrance 10, notoginseng 5, Patrinia 5, astragalus 10.

[0193] Prepared according to the method of Example 1.

Embodiment 3

[0195] Get raw material medicine (weight unit kilogram) spider incense 20, kudzu root 20, Scutellaria chinensis 20, honeysuckle 15, coptis 20, peony root 20, woody fragrance 20, notoginseng 10, Patrinia 10, astragalus 20.

[0196] Prepared according to the method of Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a Chinese medicine for effectively curing chronic colitis and ulcerative colitis with obvious therapeutic effect. Said Chinese medicine is made up by using 10 Chinese medicinal materials of valeriana jatamansi, scutellaria root, lonicera flower, notoginseng, astragalus root and others through a certain preparation process.

Description

technical field [0001] The invention relates to a Chinese patent medicine prepared from Chinese herbal medicine, in particular to a medicine for treating chronic colitis and ulcerative colitis and a preparation method thereof. Background technique [0002] Chronic colitis and ulcerative colitis are frequently-occurring and common diseases. The number of reported cases in my country has increased rapidly in recent years. Based on the statistics of cases in many hospitals, the incidence rates of the patients are 11.6 / 105 and 1.4 / 105 respectively, which may be underestimated. At present, the disease has become a common disease of the digestive system and the main cause of chronic diarrhea, which has a great impact on social productivity and personal quality of life, and has attracted great attention from all walks of life. [0003] The characteristics of colitis are: stubborn and difficult to heal, long course of disease, easy to relapse and so on. Because the disease does not ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/718A61K9/48A61P1/00A61P1/04
Inventor 杨洪英
Owner 杨洪英
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products